Author: Claudia Cilento
Author: Allan Matsui
Author: Jairo Utimi
Author: Nilva Bortoleto
Author: Camille Rodrigues da Silva
Good Manufacturing Practices
Unraveling the Abbreviated Development Path
Publication of the Public Consultation for the review of RDC 200 - what is new?
NEW REGULATORY FRAMEWORK OF API
Six suggestions for a successful Advisory Board
What is the purpose of clinical research on health products?
Incremental innovations - what are the financial benefits?
Incremental innovation: 5 suggestions that can contribute to your success
What are the new expectations for the development of incremental products and medicines?
INCREMENTAL INNOVATION: How to prepare for the changes that will come with the revision of RDC 200
COVID-19: What facilities is ANVISA providing at this time of crisis?
Why are 24% of drug registrations still rejected?
Cannabis: challenges and opportunities
API, BPF and drug dossier - How to align the processes to ensure success in registration?
NEW API REGULATORY FRAMEWORK: Will ANVISA and international manufacturers be prepared?
Publication of the new API regulatory framework: what is essential to know?
What is important about the new regulatory framework for good manufacturing practices?
Cannabis for therapeutic uses: is this a new market?
Outcome of the RDC 200 Review Working Group meeting - 02/05/20
Cannabis: the rules of the new regulation system.
Everything you need to know about the new rules for Drug Renewal.
CONTEÚDOS EXCLUSIVOS PARA AUXILIAR EM